SOST and posterior cortical atrophy: Serum sclerostin levels were significantly higher in men receiving acute or chronic ADT than PCa controls (3099 pg/mL and 2971.95 pg/mL vs. 2621.55 pg/mL, p = 0.007 and p = 0.033, respectively).